Document is current
Any future updates will be listed below
-
Authors
Abbaszadeh, Fatemeh
Azizi, Samaneh
Mobasseri, Majid
Ebrahimi-Mameghani, Mehrangiz http://orcid.org/0000-0002-0311-1289
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20100209003320n16 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
The effects of citrulline supplementation on meta-inflammation and insulin sensitivity in type 2 diabetes: a randomized, double-blind, placebo-controlled trial
https://doi.org/10.1186/s13098-021-00669-w
-
Funding
Funding for this research was provided by:
Tabriz University of Medical Sciences
- License Information
-
More Information
Article History
Received: 9 February 2021
Accepted: 23 April 2021
First Online: 5 May 2021
Declarations
:
: All aspect of this work were approved by the Ethical Committee of Tabriz University of Medical Sciences (Ethics code: IR.TBZMED.REC.1398.739) and registered at the Iranian Registry of Clinical Trials (registration no: IRCT20100209003320N16 at ExternalRef removed). All patients had been written consent before the research.
: Not applicable.
: The authors declare that they have no competing interests.
